Overexpression of CD151 Predicts Prognosis in Patients with Resected Gastric Cancer

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Yang, Yue Ming ^a   Zhang, Zhong Wei ^a   Liu, Qing Meng ^a   Sun, Yi Feng ^a   Yu, Ji Ren ^a   Xu, Wei Xing ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA3 INTEGRIN; CD151 ANTIGEN; COMPLEMENTARY DNA; LENTIVIRUS VECTOR; SHORT HAIRPIN RNA;

AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA TRANSFECTION; DOWN REGULATION; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; MOUSE; NONHUMAN; OVERALL SURVIVAL; STOMACH CANCER; STOMACH EPITHELIUM; SURVIVAL RATE; TISSUE MICROARRAY; TUMOR VOLUME;

AGED; ANTIGENS, CD151; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; HUMANS; IMMUNOBLOTTING; IMMUNOPRECIPITATION; INTEGRIN ALPHA3; MALE; MIDDLE AGED; PROGNOSIS; PROTEIN BINDING; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS;

EID: 84875309056     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058990     Document Type: Article

References (27)

1. Jemal A, Bray F, (2011) Center MM, Ferlay J, Ward E, et al (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
2. Ohtsu A, (2008) Chemotherapy for metastatic gastric cancer: past, present, and future. J Gastroenterol 43: 256-264.
3. Zhao ZS, Wang YY, Chu YQ, Ye ZY, Tao HQ, (2010) SPARC is associated with gastric cancer progression and poor survival of patients. Clin Cancer Res 16: 260-268.
4. Wang YY, Ye ZY, Zhao ZS, Tao HQ, Li SG, (2010) Systems biology approach to identification of biomarkers for metastatic progression in gastric cancer. J Cancer Res Clin Oncol 136: 135-141.
5. Wu MS, Shun CT, Wang HP, Sheu JC, Lee WJ, et al. (1997) Genetic alterations in gastric cancer: relation to histological subtypes, tumor stage, and Helicobacter pylori infection. Gastroenterology 112: 1457-1465.
6. Yanez-Mo M, Barreiro O, Gordon-Alonso M, Sala-Valdes M, Sanchez-Madrid F, (2009) Tetraspanin-enriched microdomains: a functional unit in cell plasma membranes. Trends Cell Biol 19: 434-446.
7. Hemler ME, (2005) Tetraspanin functions and associated microdomains. Nat Rev Mol Cell Biol 6: 801-811.
8. Wright MD, Moseley GW, van Spriel AB, (2004) Tetraspanin microdomains in immune cell signalling and malignant disease. Tissue Antigens 64: 533-542.
9. Hemler ME, (2008) Targeting of tetraspanin proteins-potential benefits and strategies. Nat Rev Drug Discov 7: 747-758.
10. Ashman LK, (2002) Cd151. J Biol Regul Homeost Agents 16: 223-226.
11. Zijlstra A, Lewis J, Degryse B, Stuhlmann H, Quigley JP, (2008) The inhibition of tumor cell intravasation and subsequent metastasis via regulation of in vivo tumor cell motility by the tetraspanin CD151. Cancer Cell 13: 221-234.
12. Lazo PA, (2007) Functional implications of tetraspanin proteins in cancer biology. Cancer Sci 98: 1666-1677.
13. Shi GM, Ke AW, Zhou J, Wang XY, Xu Y, et al. (2010) CD151 modulates expression of matrix metalloproteinase 9 and promotes neoangiogenesis and progression of hepatocellular carcinoma. Hepatology 52: 183-196.
14. Zheng B, Liang L, Wang C, Huang S, Cao X, et al. (2011) MicroRNA-148a suppresses tumor cell invasion and metastasis by downregulating ROCK1 in gastric cancer. Clin Cancer Res 17: 7574-7583.
15. Ke AW, Shi GM, Zhou J, Wu FZ, Ding ZB, et al. (2009) Role of overexpression of CD151 and/or c-Met in predicting prognosis of hepatocellular carcinoma. Hepatology 49: 491-503.
16. Saito Y, Sekine W, Sano R, Komatsu S, Mizuno H, et al. (2010) Potentiation of cell invasion and matrix metalloproteinase production by alpha3beta1 integrin-mediated adhesion of gastric carcinoma cells to laminin-5. Clin Exp Metastasis 27: 197-205.
17. Ke AW, Shi GM, Zhou J, Huang XY, Shi YH, et al. (2011) CD151 amplifies signaling by integrin alpha6beta1 to PI3K and induces the epithelial-mesenchymal transition in HCC cells. Gastroenterology 140: 1629-1641 e1615.
18. Takatsuki H, Komatsu S, Sano R, Takada Y, Tsuji T, (2004) Adhesion of gastric carcinoma cells to peritoneum mediated by alpha3beta1 integrin (VLA-3). Cancer Res 64: 6065-6070.
19. Huang XY, Ke AW, Shi GM, Ding ZB, Devbhandari RP, et al. (2010) Overexpression of CD151 as an adverse marker for intrahepatic cholangiocarcinoma patients. Cancer 116: 5440-5451.
20. Kwon MJ, Park S, Choi JY, Oh E, Kim YJ, et al. (2012) Clinical significance of CD151 overexpression in subtypes of invasive breast cancer. Br J Cancer 106: 923-930.
21. Tokuhara T, Hasegawa H, Hattori N, Ishida H, Taki T, et al. (2001) Clinical significance of CD151 gene expression in non-small cell lung cancer. Clin Cancer Res 7: 4109-4114.
22. Testa JE, Brooks PC, Lin JM, Quigley JP, (1999) Eukaryotic expression cloning with an antimetastatic monoclonal antibody identifies a tetraspanin (PETA-3/CD151) as an effector of human tumor cell migration and metastasis. Cancer Res 59: 3812-3820.
23. Haeuw JF, Goetsch L, Bailly C, Corvaia N, (2011) Tetraspanin CD151 as a target for antibody-based cancer immunotherapy. Biochem Soc Trans 39: 553-558.
24. Kovalenko OV, Metcalf DG, DeGrado WF, Hemler ME, (2005) Structural organization and interactions of transmembrane domains in tetraspanin proteins. BMC Struct Biol 5: 11.
25. Hemler ME, (2001) Specific tetraspanin functions. J Cell Biol 155: 1103-1107.
26. Rubinstein E, (2011) The complexity of tetraspanins. Biochem Soc Trans 39: 501-505.
27. Stipp CS, Kolesnikova TV, Hemler ME, (2003) Functional domains in tetraspanin proteins. Trends Biochem Sci 28: 106-112.